CVS Corp (CVS) 95.10 $CVS
My Dividend Portfolio: 2014 Q4 Update
Integrator - at Seeking Alpha - Sat Jan 03, 7:18AM CST
BDX: 139.86 (+0.70), GE: 25.06 (-0.21), LMT: 193.31 (+0.74), CLX: 103.87 (-0.34), HSY: 103.71 (-0.22), NKE: 95.03 (-1.12), WBK: 26.82 (-0.08), PEP: 94.44 (-0.12), SBUX: 81.44 (-0.61), CME: 88.14 (-0.51), JNJ: 104.52 (-0.05), COST: 141.61 (-0.14), BP: 38.12 (unch), MSFT: 46.76 (+0.31), CSCO: 27.61 (-0.21), YUM: 72.35 (-0.50), KO: 42.14 (-0.08), CHD: 79.09 (+0.28), COP: 68.92 (-0.14), AMGN: 159.89 (+0.60), DIS: 93.75 (-0.44), ADP: 83.29 (-0.08), CVS: 95.10 (-1.21), PG: 90.44 (-0.65), VZ: 46.96 (+0.18), CL: 69.04 (-0.15)
Walgreen Closes Alliance Boots Buyout; Renames Company - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 12:40PM CST
Walgreens Boots Alliance Inc., the first global pharmacy-led health and wellbeing enterprise, will start trading on the Nasdaq under the ticker symbol "WBA".
ABMD: 37.31 (-0.75), WBA: 76.00 (-0.20), CVS: 95.10 (-1.21), RAD: 7.63 (+0.11)
CVS Caremark (CVS) Crosses Pivot Point Support at $95.72
Comtex SmarTrend(R) - Fri Jan 02, 10:13AM CST
Shares of CVS Caremark (NYSE:CVS) opened today below their pivot of $96.79 and have already reached the first level of support at $95.72. Investors may be interested in a cross of the next downside pivot targets of $95.12 and $93.45.
CVS: 95.10 (-1.21)
Key Rite Aid sales metric climbs 5.3 percent in December
By The Associated Press - AP - Fri Jan 02, 9:01AM CST
Rite Aid's revenue from established stores climbed more than 5 percent last month, as growing prescription totals countered a hit from cheaper generic drugs for the nation's third-largest drugstore chain.
CVS: 95.10 (-1.21), RAD: 7.63 (+0.11)
After Yesterday's Decline of 1.25%, CVS Caremark Offers Investors Better Value
Comtex SmarTrend(R) - Wed Dec 31, 3:55PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $96.20 to a high of $97.87. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $97.06 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CVS: 95.10 (-1.21)
CVS Caremark Set to Possibly Rebound After Yesterday's Selloff of 1.25%
Comtex SmarTrend(R) - Wed Dec 31, 3:55PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $96.20 to a high of $97.87. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $97.06 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CVS: 95.10 (-1.21)
Rite Aid (RAD) Looks Promising; Have You Invested in It Yet? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 3:25PM CST
Rite Aid Corp. (RAD) is scoring high on the favorability radar, backed by a splendid stock performance all through 2014, having witnessed 49.4% growth year to date.
NPD: 1.54 (-0.04), CVS: 95.10 (-1.21), WMT: 85.90 (+0.02), RAD: 7.63 (+0.11)
Rite Aid, Nokia and Sirius XM, 3 Stocks Under $10 to Buy in 2015
at The Street - Wed Dec 31, 1:28PM CST
Investors looking for growth and value may find it in Rite Aid, Nokia and Sirius XM -- stocks trading under $10.
CVS: 95.10 (-1.21), MSFT: 46.76 (+0.31), WAG: 76.05 (-0.49), SIRI: 3.47 (-0.03), NOK: 8.01 (+0.15), RAD: 7.63 (+0.11)
24.1% Return Seen to Date on SmarTrend CVS Caremark Call (CVS)
Comtex SmarTrend(R) - Wed Dec 31, 11:17AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 5 months, CVS Caremark has returned 24.12% as of today's recent price of $97.54.
CVS: 95.10 (-1.21)
5 Prescriptions for $1 Billion in Cost Cuts at Walgreen
Bruce Japsen, The Motley Fool - Motley Fool - Mon Dec 29, 12:31PM CST
On Wednesday, Walgreen Company will complete its acquisition of major global drug retailer Alliance Boots and make its debut as a new holding company, Walgreens Boots Alliance, on the Nasdaq market under the ticker symbol WBA. Walgreen CEO...
CVS: 95.10 (-1.21), WAG: 76.05 (-0.49)
CVS Caremark (CVS) Approaches New Downside Target of $97.56
Comtex SmarTrend(R) - Mon Dec 29, 11:40AM CST
CVS Caremark (NYSE:CVS) has opened bearishly below the pivot of $98.26 today and has reached the first level of support at $97.91. Investors may be interested in a cross of the next downside pivot targets of $97.56 and $96.86.
CVS: 95.10 (-1.21)
Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.
George Budwell, The Motley Fool - Motley Fool - Sun Dec 28, 12:05PM CST
Source: Flickr via user Derek Gavey. Pharmaceutical companies have had some of the best-performing stocks over the last couple of years thanks to an innovation boom that has produced a host of new game-changing drugs, from Gilead Sciences ' ...
ESRX: 84.65 (-0.02), GILD: 94.91 (+0.65), MRK: 57.19 (+0.40), IBB: 306.34 (+2.99), CVS: 95.10 (-1.21), ABBV: 65.89 (+0.45), GSK: 42.37 (-0.37), NVS: 92.25 (-0.41)
3 Can't Miss Quotes from Rite Aid Corporation's CEO
Todd Campbell, The Motley Fool - Motley Fool - Sun Dec 28, 9:57AM CST
Source: Rite Aid Corp. Rite Aid Corporation went from stock market darling to dud this past year, but solid fiscal third quarter results suggest that shares could return to their winning ways. Despite operating 23 fewer stores during the...
MCK: 207.20 (-0.38), CVS: 95.10 (-1.21), WAG: 76.05 (-0.49), RAD: 7.63 (+0.11)
Cardinal Health (CAH) Rides High on Accretive Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 10:10AM CST
We are impressed by the fact that Cardinal Health (CAH) is focused on its acquisition-driven strategy and continued investments in key growth businesses.
MCK: 207.20 (-0.38), CAH: 80.51 (-0.22), CVS: 95.10 (-1.21), HSIC: 136.84 (+0.69)
Continued Increase In Sales Earns CVS A Bullish Thesis
Equity Watch - at Seeking Alpha - Thu Dec 25, 2:08AM CST
CVS: 95.10 (-1.21)
Could Express Scripts Holding Company's Gilead Gamble Backfire?
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 12:03PM CST
Source: CVS Health. In case you missed it, the hepatitis C community was turned on its head this past weekend with the approval of a new hepatitis C compound and a major move by a pharmacy-benefits manager to strike a long-term deal with that...
ESRX: 84.65 (-0.02), GILD: 94.91 (+0.65), CVS: 95.10 (-1.21), ABBV: 65.89 (+0.45), WAG: 76.05 (-0.49)
CVS Caremark Has Returned 24.7% Since SmarTrend Recommendation (CVS)
Comtex SmarTrend(R) - Wed Dec 24, 9:42AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 5 months, CVS Caremark has returned 24.69% as of today's recent price of $97.98.
CVS: 95.10 (-1.21)
Update: Walgreen Earnings Put The Green In Walgreen
The Specialist - at Seeking Alpha - Tue Dec 23, 1:39PM CST
CVS: 95.10 (-1.21), WAG: 76.05 (-0.49), RAD: 7.63 (+0.11)
Walgreen Q1 Earnings Top On Strong Prescription Sales
at Investor's Business Daily - Tue Dec 23, 10:50AM CST
A record number of prescriptions helped boost Walgreen 's (WAG) first-quarter results above analyst estimates. On Tuesday, the drugstore chain reported a 12.5% increase in earnings to 81 cents per share. Analysts polled by Thomson Reuters were...
CVS: 95.10 (-1.21), WAG: 76.05 (-0.49), RAD: 7.63 (+0.11)
Today's Market: Moving Higher On Strong Earnings And Pricing Power
Matthew Smith - at Seeking Alpha - Tue Dec 23, 10:48AM CST
SPY: 205.43 (-0.11), HTZ: 25.02 (+0.08), JPM: 62.49 (-0.09), GMCR: 131.97 (-0.43), DIA: 177.94 (+0.06), SNE: 20.56 (+0.09), CVS: 95.10 (-1.21), WAG: 76.05 (-0.49)
My Dividend Portfolio: 2014 Q4 Update
Integrator - at Seeking Alpha - Sat Jan 03, 7:18AM CST
BDX: 139.86 (+0.70), GE: 25.06 (-0.21), LMT: 193.31 (+0.74), CLX: 103.87 (-0.34), HSY: 103.71 (-0.22), NKE: 95.03 (-1.12), WBK: 26.82 (-0.08), PEP: 94.44 (-0.12), SBUX: 81.44 (-0.61), CME: 88.14 (-0.51), JNJ: 104.52 (-0.05), COST: 141.61 (-0.14), BP: 38.12 (unch), MSFT: 46.76 (+0.31), CSCO: 27.61 (-0.21), YUM: 72.35 (-0.50), KO: 42.14 (-0.08), CHD: 79.09 (+0.28), COP: 68.92 (-0.14), AMGN: 159.89 (+0.60), DIS: 93.75 (-0.44), ADP: 83.29 (-0.08), CVS: 95.10 (-1.21), PG: 90.44 (-0.65), VZ: 46.96 (+0.18), CL: 69.04 (-0.15)
Walgreen Closes Alliance Boots Buyout; Renames Company - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 12:40PM CST
Walgreens Boots Alliance Inc., the first global pharmacy-led health and wellbeing enterprise, will start trading on the Nasdaq under the ticker symbol "WBA".
ABMD: 37.31 (-0.75), WBA: 76.00 (-0.20), CVS: 95.10 (-1.21), RAD: 7.63 (+0.11)
CVS Caremark (CVS) Crosses Pivot Point Support at $95.72
Comtex SmarTrend(R) - Fri Jan 02, 10:13AM CST
Shares of CVS Caremark (NYSE:CVS) opened today below their pivot of $96.79 and have already reached the first level of support at $95.72. Investors may be interested in a cross of the next downside pivot targets of $95.12 and $93.45.
CVS: 95.10 (-1.21)
Key Rite Aid sales metric climbs 5.3 percent in December
By The Associated Press - AP - Fri Jan 02, 9:01AM CST
Rite Aid's revenue from established stores climbed more than 5 percent last month, as growing prescription totals countered a hit from cheaper generic drugs for the nation's third-largest drugstore chain.
CVS: 95.10 (-1.21), RAD: 7.63 (+0.11)
After Yesterday's Decline of 1.25%, CVS Caremark Offers Investors Better Value
Comtex SmarTrend(R) - Wed Dec 31, 3:55PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $96.20 to a high of $97.87. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $97.06 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CVS: 95.10 (-1.21)
CVS Caremark Set to Possibly Rebound After Yesterday's Selloff of 1.25%
Comtex SmarTrend(R) - Wed Dec 31, 3:55PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $96.20 to a high of $97.87. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $97.06 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CVS: 95.10 (-1.21)
Rite Aid (RAD) Looks Promising; Have You Invested in It Yet? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 3:25PM CST
Rite Aid Corp. (RAD) is scoring high on the favorability radar, backed by a splendid stock performance all through 2014, having witnessed 49.4% growth year to date.
NPD: 1.54 (-0.04), CVS: 95.10 (-1.21), WMT: 85.90 (+0.02), RAD: 7.63 (+0.11)
Rite Aid, Nokia and Sirius XM, 3 Stocks Under $10 to Buy in 2015
at The Street - Wed Dec 31, 1:28PM CST
Investors looking for growth and value may find it in Rite Aid, Nokia and Sirius XM -- stocks trading under $10.
CVS: 95.10 (-1.21), MSFT: 46.76 (+0.31), WAG: 76.05 (-0.49), SIRI: 3.47 (-0.03), NOK: 8.01 (+0.15), RAD: 7.63 (+0.11)
24.1% Return Seen to Date on SmarTrend CVS Caremark Call (CVS)
Comtex SmarTrend(R) - Wed Dec 31, 11:17AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 5 months, CVS Caremark has returned 24.12% as of today's recent price of $97.54.
CVS: 95.10 (-1.21)
5 Prescriptions for $1 Billion in Cost Cuts at Walgreen
Bruce Japsen, The Motley Fool - Motley Fool - Mon Dec 29, 12:31PM CST
On Wednesday, Walgreen Company will complete its acquisition of major global drug retailer Alliance Boots and make its debut as a new holding company, Walgreens Boots Alliance, on the Nasdaq market under the ticker symbol WBA. Walgreen CEO...
CVS: 95.10 (-1.21), WAG: 76.05 (-0.49)
CVS Caremark (CVS) Approaches New Downside Target of $97.56
Comtex SmarTrend(R) - Mon Dec 29, 11:40AM CST
CVS Caremark (NYSE:CVS) has opened bearishly below the pivot of $98.26 today and has reached the first level of support at $97.91. Investors may be interested in a cross of the next downside pivot targets of $97.56 and $96.86.
CVS: 95.10 (-1.21)
Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.
George Budwell, The Motley Fool - Motley Fool - Sun Dec 28, 12:05PM CST
Source: Flickr via user Derek Gavey. Pharmaceutical companies have had some of the best-performing stocks over the last couple of years thanks to an innovation boom that has produced a host of new game-changing drugs, from Gilead Sciences ' ...
ESRX: 84.65 (-0.02), GILD: 94.91 (+0.65), MRK: 57.19 (+0.40), IBB: 306.34 (+2.99), CVS: 95.10 (-1.21), ABBV: 65.89 (+0.45), GSK: 42.37 (-0.37), NVS: 92.25 (-0.41)
3 Can't Miss Quotes from Rite Aid Corporation's CEO
Todd Campbell, The Motley Fool - Motley Fool - Sun Dec 28, 9:57AM CST
Source: Rite Aid Corp. Rite Aid Corporation went from stock market darling to dud this past year, but solid fiscal third quarter results suggest that shares could return to their winning ways. Despite operating 23 fewer stores during the...
MCK: 207.20 (-0.38), CVS: 95.10 (-1.21), WAG: 76.05 (-0.49), RAD: 7.63 (+0.11)
Cardinal Health (CAH) Rides High on Accretive Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 10:10AM CST
We are impressed by the fact that Cardinal Health (CAH) is focused on its acquisition-driven strategy and continued investments in key growth businesses.
MCK: 207.20 (-0.38), CAH: 80.51 (-0.22), CVS: 95.10 (-1.21), HSIC: 136.84 (+0.69)
Continued Increase In Sales Earns CVS A Bullish Thesis
Equity Watch - at Seeking Alpha - Thu Dec 25, 2:08AM CST
CVS: 95.10 (-1.21)
Could Express Scripts Holding Company's Gilead Gamble Backfire?
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 12:03PM CST
Source: CVS Health. In case you missed it, the hepatitis C community was turned on its head this past weekend with the approval of a new hepatitis C compound and a major move by a pharmacy-benefits manager to strike a long-term deal with that...
ESRX: 84.65 (-0.02), GILD: 94.91 (+0.65), CVS: 95.10 (-1.21), ABBV: 65.89 (+0.45), WAG: 76.05 (-0.49)
CVS Caremark Has Returned 24.7% Since SmarTrend Recommendation (CVS)
Comtex SmarTrend(R) - Wed Dec 24, 9:42AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 5 months, CVS Caremark has returned 24.69% as of today's recent price of $97.98.
CVS: 95.10 (-1.21)
Update: Walgreen Earnings Put The Green In Walgreen
The Specialist - at Seeking Alpha - Tue Dec 23, 1:39PM CST
CVS: 95.10 (-1.21), WAG: 76.05 (-0.49), RAD: 7.63 (+0.11)
Walgreen Q1 Earnings Top On Strong Prescription Sales
at Investor's Business Daily - Tue Dec 23, 10:50AM CST
A record number of prescriptions helped boost Walgreen 's (WAG) first-quarter results above analyst estimates. On Tuesday, the drugstore chain reported a 12.5% increase in earnings to 81 cents per share. Analysts polled by Thomson Reuters were...
CVS: 95.10 (-1.21), WAG: 76.05 (-0.49), RAD: 7.63 (+0.11)
Today's Market: Moving Higher On Strong Earnings And Pricing Power
Matthew Smith - at Seeking Alpha - Tue Dec 23, 10:48AM CST
SPY: 205.43 (-0.11), HTZ: 25.02 (+0.08), JPM: 62.49 (-0.09), GMCR: 131.97 (-0.43), DIA: 177.94 (+0.06), SNE: 20.56 (+0.09), CVS: 95.10 (-1.21), WAG: 76.05 (-0.49)
